OncoSil Medical (ASX:OSL) First OncoSil(TM) treatment in Germany
By API User
Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the first patient treatment in Germany using the OncoSil™ device. The successful treatment was performed on 15 October 2025 at Universitätsklinikum Augsburg, a leading university hospital renowned for its excellence in oncology. This important milestone marks the commencement of OncoSil’s commercial activities in Germany, the … Continued